BCN Biosciences is looking for research and drug development collaboration with other biotech and pharma companies.
Please email us at contact@bcnbio.com for any collaborative or business development requests.
RESEARCH
An ongoing research program at BCN is the investigation of new endothelial derived gene products and their importance as therapeutic targets.
PORTFOLIO
BCN has been successful in its steps to build a portfolio of early stage anticancer therapeutics and an experienced team who understand both early and late stage drug development.